- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02610114
Improvement of Cell Selection in Reproductive Techniques
A New Method to Improve the Selection of Zygotes in the Context of Assisted Reproductive Medicine. A Randomized Controlled Blinded Monocenter Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It is the aim of this trial to use a new computerized selection method, in addition to the current and world-wide used scoring system of fertilized oocytes (zygotes) implemented by Scott in 1998, to determine whether this leads to an increase in pregnancy rates in women undergoing assisted reproductive techniques. If successful this could in the future lead to a reduction in the numbers of embryos required to achieve a pregnancy. Transferring only one embryo means minimizing the incidence of high order multiple pregnancies.
Regularly couples gain several fertilized oocytes (zygotes) due to artificial reproductive techniques. As a routine, these cells are archived using pictures and videos for quality and safety reasons in different stages of development. Because it is planned to transfer only one or two developed embryos to the uterus, investigators have to select the zygotes with the highest potential for implantation and pregnancy. The remaining cells are preserved using vitrification.
In the study, investigators use in addition to the established Zygote-score (Z-score) by Scott a new selection method for one group of patients: The quality of the zygotes of all patients is classified according to the described Scott system. Patients are randomized to two groups. Group 1 is the control group without any further intervention. If needed for selection, the quality of the zygotes of the patients of group 2 is additionally scored with a new method. The pictures of the cells, already taken for quality and safety reasons, are taken and the cells surface is analysed using a computer algorithm.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jürgen Weiss, Professor
- Phone Number: +41 41 205 36 06
- Email: juergen.weiss@luks.ch
Study Contact Backup
- Name: Roger Getzmann
- Phone Number: +41 41 205 28 40
- Email: roger.getzmann@luks.ch
Study Locations
-
-
-
Luzern, Switzerland, 6000 Luzern 16
- Recruiting
- Neue Frauenklinik
-
Contact:
- Roger Getzmann
- Phone Number: +41 41 205 28 40
- Email: roger.getzmann@luks.ch
-
Contact:
- Jürgen Weiss, Professor
- Phone Number: +41 41 205 36 08
- Email: juergen.weiss@luks.ch
-
Principal Investigator:
- Jürgen Weiss, Professor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria (for both male and female, couples):
- Woman with age 18 years or older
- Man with age 18 years or older
- Couples who could gain fertilized cells after In vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) after hormonal stimulation due to sterility treatments
- Couples presenting negative blood samples of human immunodeficiency virus (HIV) and Hepatitis B/C
- Signed routine contracts between hospital and patient wanting assisted reproductive technology (ART)
- Signed informed study consent
- Expectation of life more than 18 years
- No medical contraindication to become pregnant (female)
- Routine criteria for assisted reproductive techniques
Exclusion criteria (for female):
- Poor health status acc. to Investigator's judgement
- Expectation of life below 18 years
- Risk of ovarian hyperstimulation syndrome
- Avital cells (cells that do not further develop or die)
- Treatment due to fertility preservation, e.g. in case of cancer
- Problems after stimulation and follicle puncture
- Endometrial pathologies like polyps, submucous fibroids, etc.
- Any preceding stimulation cycle with endometrial thickness below 6mm
- Less than 4 fertilized oocytes
- Patient (and partner) wishes single embryo Transfer
- Failure to become pregnant with new zygote selection method
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Z-Score and computer algorithm
|
In addition to the routine Z-score for zygote selection, if needed, the photographs of the zygotes already taken for quality and safety reasons are analysed using the new computer algorithm.
Within a few minutes it generates a score, determining the quality of the cells.
The two best cells upon Z-score result and new computer algorithm result are selected for first transfer.
|
ACTIVE_COMPARATOR: Z-Score
|
After fertilisation pronuclei and nucleoli can be seen inside the cells by microscope.
Routinely, the alignment of nucleoli can be used generating a score, the Z-score 1-4, established by Scott.
Two zygotes getting the best Z-score are selected for cell culture and the cells that develop to embryo stage are used for first transfer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical pregnancy
Time Frame: min. 4 weeks after embryo transfer
|
Clinical pregnancy is defined as a pregnancy diagnosed by ultrasonographic visualization of one or more gestational sacs or definitive clinical signs of pregnancy.
It includes ectopic pregnancy.
|
min. 4 weeks after embryo transfer
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ongoing clinical pregnancy
Time Frame: min. 9 weeks after embryo transfer
|
Clinical pregnancy is defined as a pregnancy diagnosed by ultrasonographic visualization of one or more gestational sacs or definitive clinical signs of pregnancy.
It includes ectopic pregnancy.
|
min. 9 weeks after embryo transfer
|
Life Birth
Time Frame: through study completion, an average of 40 weeks after last menstrual period
|
A live birth is defined as the complete expulsion or extraction from its mother of a product of fertilization, irrespective of the duration of the pregnancy, which, after such separation, breathes or shows any other evidence of life, such as heart beat, umbilical cord pulsation, or definite movement of voluntary muscle, irrespective of whether the umbilical cord has been cut or the placenta is attached.
|
through study completion, an average of 40 weeks after last menstrual period
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Jürgen Weiss, Professor, Luzerner Kantonsspital, Neue Frauenklinik
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REPROLUKS 002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Z-Score and computer algorithm
-
NYU Langone HealthCompleted
-
The Defense and Veterans Brain Injury CenterCompletedTraumatic Brain InjuryUnited States
-
Yale UniversityAlnylam Pharmaceuticals IncNot yet recruitingTransthyretin AmyloidosisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHead and Neck CarcinomaUnited States
-
Taipei Medical UniversityRecruiting
-
Stanford UniversityCompletedAtrial Fibrillation | Arrhythmias, Cardiac | Atrial Flutter | Atrial TachycardiaUnited States
-
Karolinska InstitutetRegion Stockholm; Stiftelsen Sunnerdahls Handikappfond; Swedish Foundation for... and other collaboratorsCompletedAttention Deficit DisorderSweden
-
Stanford UniversityCompletedType 1 DiabetesUnited States
-
University Hospital, Basel, SwitzerlandInnosuisse - Swiss Innovation AgencyCompleted